The THOR IDE Study
Recruiting · Not applicable · NCT05916950
Conditions: Peripheral Artery Disease, Peripheral Artery Stenosis, Peripheral Artery Calcification, PAD
At a glance
- Research payments reported, 2025
- $772,207
- U.S. investigators named
- 23
- Sites paid
- 21
- Planned or actual enrollment
- 155
About the trial
- Sponsor
- Philips Clinical & Medical Affairs Global (with NAMSA, Syntropic)
- Tested
- Thor laser atherectomy (device)
- Dates
- Started 2024-10-29; completion 2027-12
- Results posted
- Not yet
The goal of this clinical trial is to test the Thor system in adult (≥ 18 year old) patients with de novo (new, never treated) calcified lesions in infrainguinal (leg) arteries (peripheral artery disease or PAD). The main question\[s\] it aims to answer are: * Is the Thor system safe in treating these lesions * Does the Thor system work to treat these lesions Participants will: * Receive treatment with the Thor system * Have follow-up visits at Discharge, 30 days, 6 months, and 12 months
From ClinicalTrials.gov, last updated 2026-11-05. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Philips North America LLC reported $772,207 in research payments for this study in 2025 (56 payments).
Products named: Thor
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Leonardo C. Clavijo, M.D. Interventional Cardiology · Saint Helena, CA
- Bilal Aijaz, M.D Interventional Cardiology · Aurora, CO
- Ashish K. Gupta, M.D. Cardiology · Winter Park, FL
- Ankur Lodha, M.D Interventional Cardiology · Lafayette, LA
- Craig M. Walker, MD Interventional Cardiology · Houma, LA
- Stephen J. Hoenig, MD Vascular Surgery · Leominster, MA
- Richard H. Pin, MD Vascular Surgery · North Dartmouth, MA
- Nathan J. Aranson, M.D. Vascular Surgery · S Portland, ME
- Herbert D. Aronow, M.D. Interventional Cardiology · Ypsilanti, MI
- Virendra Patel, M.D. Cardiology · Brick, NJ
- Micah M. Watts, MD Interventional Radiology · Galloway, NJ
- Ramzan M. Zakir, M.D. Interventional Cardiology · New Brunswick, NJ
- Prakash Krishnan, M.D. Interventional Cardiology · New York, NY
- Sagger H. Mawri, M.D. Interventional Cardiology · Dayton, OH
- Anderson P. Mehrle, MD Cardiology · Bartlesville, OK
- Mary M. Costantino, MD Interventional Radiology · Portland, OR
- William B. Bachinsky, MD Cardiology · Mechanicsburg, PA
- Elizabeth A. Genovese, M.D. Vascular Surgery · Philadelphia, PA
- Antonis Pratsos, M.D. Interventional Cardiology · Broomall, PA
- Peter A. Soukas, M.D. Interventional Cardiology · Providence, RI
- Sameh Sayfo Interventional Cardiology · Plano, TX
- Michael C. Siah Vascular Surgery · Dallas, TX
- David J. Dexter II, MD Vascular Surgery · Norfolk, VA
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Vascular Breakthroughs LLC $145,483
- Cardiovascular Institute of the South Clinical Research Corp $135,230
- Vascular Breakthroughs, LLC $68,631
- Baylor Scott & White Research Institute $53,917
- Ut Southwestern Medical Center $37,500
- Guardian Research Organization LLC $37,339
- Hospital of Univ of Pennsylvania, PA $34,398
- Ascension St John $33,841
- Orca Research Group (heart and Vascular Institute of Central Jersey) $31,877
- Henry Ford Health Hospital, MI $29,800
- Sentara Hospitals $26,276
- Wright State University $25,879
- Pinnacle Health Cardiovascular Institute, Inc $22,000
- Denver Research Institute $21,153
- Icahn School of Medicine at Mount Sinai $17,893
- The Trustees of Columbia Universtiy in The City of New York $17,175
- Adventist Health St. Helena $10,975
- Atlantic Medical Imaging, LLC $8,000
- Lankenau Institute for Medical Research $7,000
- The Miriam Hospital, RI $6,500
- Southcoast Hospitals Group $1,340
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.